In addition, an increasing number of studies have shown that VP has an anti‐proliferation effect on various cancers, including melanoma, prostate, liver, esophageal, and lung cancer.54, 55, 56, 57, 58 These findings indicate that YAP1 might become a new drug target in GC treatment, but further investigation is needed for clinical transformation. This evidence concerns the gene YAP1 and lung carcinoma.